TrialStem cell research & therapy2020

Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.

Emin Özmert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.